Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambria Investment Management is an independent investment advisory firm specializing in quantitative asset management and the management of exchange-traded funds (ETFs). Founded in 2006 by Mebane Faber and Eric Richardson, the firm is recognized for its research-driven approach to global value, shareholder yield, and tactical asset allocation strategies. While Cambria is primarily a financial services provider rather than a biotechnology company, it manages thematic investment products such as the Cambria Cannabis ETF (TOKE), which provides exposure to companies in the legal cannabis and hemp industries. The firm is headquartered in Manhattan Beach, California, and serves a broad range of institutional and retail investors through its rules-based investment solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cambria Investment Management.